JPWO2020255574A5 - - Google Patents
Download PDFInfo
- Publication number
- JPWO2020255574A5 JPWO2020255574A5 JP2021527435A JP2021527435A JPWO2020255574A5 JP WO2020255574 A5 JPWO2020255574 A5 JP WO2020255574A5 JP 2021527435 A JP2021527435 A JP 2021527435A JP 2021527435 A JP2021527435 A JP 2021527435A JP WO2020255574 A5 JPWO2020255574 A5 JP WO2020255574A5
- Authority
- JP
- Japan
- Prior art keywords
- spinal cord
- drug delivery
- drug
- composition
- spinal
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 238000012377 drug delivery Methods 0.000 claims 7
- 239000000203 mixture Substances 0.000 claims 7
- 208000029033 Spinal Cord disease Diseases 0.000 claims 5
- 239000003814 drug Substances 0.000 claims 4
- 229940079593 drug Drugs 0.000 claims 4
- 108090000765 processed proteins & peptides Proteins 0.000 claims 3
- 102100032187 Androgen receptor Human genes 0.000 claims 2
- 206010008025 Cerebellar ataxia Diseases 0.000 claims 2
- 208000000094 Chronic Pain Diseases 0.000 claims 2
- 101000775732 Homo sapiens Androgen receptor Proteins 0.000 claims 2
- 208000002193 Pain Diseases 0.000 claims 2
- 239000002202 Polyethylene glycol Substances 0.000 claims 2
- 208000032319 Primary lateral sclerosis Diseases 0.000 claims 2
- 208000010112 Spinocerebellar Degenerations Diseases 0.000 claims 2
- 206010046298 Upper motor neurone lesion Diseases 0.000 claims 2
- 208000006269 X-Linked Bulbo-Spinal Atrophy Diseases 0.000 claims 2
- 206010002026 amyotrophic lateral sclerosis Diseases 0.000 claims 2
- 229920001400 block copolymer Polymers 0.000 claims 2
- 230000002209 hydrophobic effect Effects 0.000 claims 2
- 201000010901 lateral sclerosis Diseases 0.000 claims 2
- 208000005264 motor neuron disease Diseases 0.000 claims 2
- 239000008194 pharmaceutical composition Substances 0.000 claims 2
- 229920000728 polyester Polymers 0.000 claims 2
- 229920001223 polyethylene glycol Polymers 0.000 claims 2
- 208000020431 spinal cord injury Diseases 0.000 claims 2
- 208000002320 spinal muscular atrophy Diseases 0.000 claims 2
- 125000003275 alpha amino acid group Chemical group 0.000 claims 1
- 239000000693 micelle Substances 0.000 claims 1
- 210000000278 spinal cord Anatomy 0.000 claims 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2019115688 | 2019-06-21 | ||
| JP2019115688 | 2019-06-21 | ||
| PCT/JP2020/018512 WO2020255574A1 (ja) | 2019-06-21 | 2020-05-07 | 薬物送達用組成物および医薬組成物 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JPWO2020255574A1 JPWO2020255574A1 (https=) | 2020-12-24 |
| JPWO2020255574A5 true JPWO2020255574A5 (https=) | 2022-05-09 |
| JP7211603B2 JP7211603B2 (ja) | 2023-01-24 |
Family
ID=74037223
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021527435A Active JP7211603B2 (ja) | 2019-06-21 | 2020-05-07 | 薬物送達用組成物および医薬組成物 |
Country Status (3)
| Country | Link |
|---|---|
| US (1) | US20220241422A1 (https=) |
| JP (1) | JP7211603B2 (https=) |
| WO (1) | WO2020255574A1 (https=) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2025004645A1 (ja) | 2023-06-28 | 2025-01-02 | 国立大学法人徳島大学 | 核酸送達用組成物及び核酸含有組成物 |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2252993T3 (es) * | 1998-12-09 | 2006-05-16 | Chiron Corporation | Administracion de agentes neurotroficos al sistema nervioso central. |
| JP7246730B2 (ja) * | 2017-07-11 | 2023-03-28 | 学校法人東京薬科大学 | 核酸送達用組成物及び核酸含有組成物 |
-
2020
- 2020-05-07 WO PCT/JP2020/018512 patent/WO2020255574A1/ja not_active Ceased
- 2020-05-07 JP JP2021527435A patent/JP7211603B2/ja active Active
- 2020-05-07 US US17/620,192 patent/US20220241422A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| RU2471867C2 (ru) | Гиалуронидаза и способ ее применения | |
| JP2014521684A5 (https=) | ||
| JP2020023567A5 (https=) | ||
| JP2010500399A5 (https=) | ||
| JP2011523857A5 (https=) | ||
| JP2010515686A5 (https=) | ||
| JP2020503262A5 (ja) | アクチビンＩＩａ型受容体変異体および同変異体を含む医薬組成物 | |
| ES2661860T3 (es) | Péptido antibiótico y método de su preparación, y aplicación del mismo | |
| JP2018512454A5 (https=) | ||
| JP2020169191A5 (https=) | ||
| JP2015502336A5 (https=) | ||
| JP2011518179A5 (https=) | ||
| HRP20041108B1 (hr) | Peptidi povezani sa tumorom koji se vežu na mhc molekule | |
| WO2008039483A3 (en) | Modified self-assembling peptides | |
| JP2014525752A5 (https=) | ||
| JP2006506942A5 (https=) | ||
| JP2016511751A5 (https=) | ||
| CN106414749A (zh) | 用于胃肠给予rna的组合物 | |
| JP2019513752A5 (https=) | ||
| US20240269302A1 (en) | Nanoparticle comprising peptide-lipid conjugate for delivering oligonucleotide into target cell and pharmaceutical composition comprising same | |
| CN103459419B (zh) | 具有抗炎活性的基于人乳铁蛋白的肽 | |
| JP2009537563A5 (https=) | ||
| JPWO2020255574A5 (https=) | ||
| JP2023093634A5 (https=) | ||
| JP2025122021A5 (https=) |